These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 34478588

  • 1. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
    Boyd C, Hassig T, MacLaren R.
    Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
    [Abstract] [Full Text] [Related]

  • 2. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
    PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group, Young PJ, Bagshaw SM, Forbes AB, Nichol AD, Wright SE, Bailey M, Bellomo R, Beasley R, Brickell K, Eastwood GM, Gattas DJ, van Haren F, Litton E, Mackle DM, McArthur CJ, McGuinness SP, Mouncey PR, Navarra L, Opgenorth D, Pilcher D, Saxena MK, Webb SA, Wiley D, Rowan KM.
    JAMA; 2020 Feb 18; 323(7):616-626. PubMed ID: 31950977
    [Abstract] [Full Text] [Related]

  • 3. Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Hammond DA, Kathe N, Shah A, Martin BC.
    Pharmacotherapy; 2017 Jan 18; 37(1):43-53. PubMed ID: 27809338
    [Abstract] [Full Text] [Related]

  • 4. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R, Reynolds PM, Allen RR.
    JAMA Intern Med; 2014 Apr 18; 174(4):564-74. PubMed ID: 24535015
    [Abstract] [Full Text] [Related]

  • 5. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM, MacLaren R.
    Pharmacotherapy; 2019 Mar 18; 39(3):408-420. PubMed ID: 30101529
    [Abstract] [Full Text] [Related]

  • 6. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X, Fang H, Xu J, Chen P, Hu X, Chen B, Wang H, Hu C, Xu Z.
    BMC Gastroenterol; 2019 Nov 21; 19(1):193. PubMed ID: 31752703
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y, Ge L, Ye Z, Siemieniuk RA, Reintam Blaser A, Wang X, Perner A, Møller MH, Alhazzani W, Cook D, Guyatt GH.
    Intensive Care Med; 2020 Nov 21; 46(11):1987-2000. PubMed ID: 32833040
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.
    Alshamsi F, Belley-Cote E, Cook D, Almenawer SA, Alqahtani Z, Perri D, Thabane L, Al-Omari A, Lewis K, Guyatt G, Alhazzani W.
    Crit Care; 2016 May 04; 20(1):120. PubMed ID: 27142116
    [Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ.
    Crit Care Med; 2013 Mar 04; 41(3):693-705. PubMed ID: 23318494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
    Lee TC, Goodwin Wilson M, Lawandi A, McDonald EG.
    Am J Med; 2021 Mar 04; 134(3):e184-e188. PubMed ID: 32931766
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Barbateskovic M, Marker S, Granholm A, Anthon CT, Krag M, Jakobsen JC, Perner A, Wetterslev J, Møller MH.
    Intensive Care Med; 2019 Feb 04; 45(2):143-158. PubMed ID: 30680444
    [Abstract] [Full Text] [Related]

  • 15. Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis.
    Kondo Y, Ohbe H, Matsui H, Fushimi K, Tanaka H, Yasunaga H.
    BMJ Open; 2020 Sep 29; 10(9):e037534. PubMed ID: 32994240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 Receptor Blockers for Preventing Clinically Important Gastrointestinal Bleeding During Intensive Care: A Population-Based Study.
    Lilly CM, Aljawadi M, Badawi O, Onukwugha E, Tom SE, Magder LS, Harris I.
    Chest; 2018 Sep 29; 154(3):557-566. PubMed ID: 29856970
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R, Campbell J.
    Crit Care Med; 2014 Apr 29; 42(4):809-15. PubMed ID: 24365863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.